Immagina Biotechnology

Our mission is to empower scientists to discover the mechanisms of translational control involved in many diseases and encrypted into ribosomes, bringing to the market breakthrough solutions to solve scientist and patients needs. Our vision is to forge a path to increased understanding of how the ribosomal machine, translational control and the translatome impact disease pathways, ultimately yielding new products and biomarker targets for disease therapies. Our mission is to develop a platform technology dedicated to unlock the therapeutic potential of ribosomes. As “The ribosome company” we develop sophisticated tools to capture ribosomes in an active state and characterize their components. The present platform includes IP covering our technologies and is dedicated to research-use-only (RUO) products with the potential to accelerate the path toward the discovery of novel therapeutic strategies in cancer, other human diseases, and congenital disorders. IMMAGINA is expected to fully underpin the immense diagnostic potential of a recently developed product portfolio for better decisions in precision medicine and better health. Our solutions focus on accuracy and simplicity so that researchers can implement their own ribosome profiling and translatome studies regardless of their RNA translation expertise. Papers most proud of: Multifunctional Branched Gold–Carbon Nanotube Hybrid for Cell Imaging and Drug Delivery.